Astera Labs, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $852.5M | $396.3M | $115.8M | $79.9M | — |
| Cost of revenue | $207.3M | $93.6M | $36.0M | $21.2M | — |
| Gross profit | $645.3M | $302.7M | $79.8M | $58.7M | — |
| Research and development | $304.0M | $200.8M | $73.4M | $73.7M | — |
| Operating expenses | $471.8M | $418.8M | $109.3M | $118.9M | — |
| Operating income | $173.4M | -$116.1M | -$29.5M | -$60.2M | — |
| Pretax income | $218.2M | -$81.8M | -$22.9M | -$57.6M | — |
| Income tax expense | -$981,000 | $1.6M | $3.3M | $764,000 | — |
| Net income | $219.1M | -$83.4M | -$26.3M | -$58.3M | — |
| Balance Sheet | |||||
| Cash and equivalents | $167.6M | $79.6M | $45.1M | — | — |
| Current assets | $1.4B | $1.0B | $185.8M | — | — |
| Total assets | $1.5B | $1.1B | $196.3M | — | — |
| Current liabilities | $133.0M | $86.5M | $35.1M | — | — |
| Total liabilities | $168.2M | $89.7M | $38.9M | — | — |
| Stockholders' equity | $1.4B | $964.8M | -$97.7M | -$85.3M | -$39.8M |
| Cash Flow Statement | |||||
| Cash from operations | $319.3M | $136.7M | -$12.7M | -$35.9M | — |
| Depreciation and amortization | $6.8M | $3.2M | $1.8M | $807,000 | — |
| Stock-based compensation | $160.0M | $234.6M | $10.7M | $30.2M | — |
| Capital expenditure | $37.5M | $34.2M | $2.8M | $3.9M | — |
| Free cash flow | $281.8M | $102.4M | -$15.5M | -$39.8M | — |
| Share repurchases | $0 | $1.1M | $210,000 | $313,000 | — |
| Impairments | $0 | $0 | $0 | — | — |
Shares outstanding 171.4M · Free float 84.3%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.